232 related articles for article (PubMed ID: 38321095)
1. Network-based drug repurposing for schizophrenia.
Truong TTT; Liu ZSJ; Panizzutti B; Kim JH; Dean OM; Berk M; Walder K
Neuropsychopharmacology; 2024 May; 49(6):983-992. PubMed ID: 38321095
[TBL] [Abstract][Full Text] [Related]
2. Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorder.
Truong TTT; Liu ZSJ; Panizzutti B; Dean OM; Berk M; Kim JH; Walder K
J Affect Disord; 2024 Apr; 350():230-239. PubMed ID: 38190860
[TBL] [Abstract][Full Text] [Related]
3. Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach.
Gaspar HA; Breen G
Sci Rep; 2017 Sep; 7(1):12460. PubMed ID: 28963561
[TBL] [Abstract][Full Text] [Related]
4. Revisiting Antipsychotic Drug Actions Through Gene Networks Associated With Schizophrenia.
Kauppi K; Rosenthal SB; Lo MT; Sanyal N; Jiang M; Abagyan R; McEvoy LK; Andreassen OA; Chen CH
Am J Psychiatry; 2018 Jul; 175(7):674-682. PubMed ID: 29495895
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
[TBL] [Abstract][Full Text] [Related]
6. Exploring schizophrenia drug-gene interactions through molecular network and pathway modeling.
Putnam DK; Sun J; Zhao Z
AMIA Annu Symp Proc; 2011; 2011():1127-33. PubMed ID: 22195173
[TBL] [Abstract][Full Text] [Related]
7. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
Zador Z; King AT; Geifman N
PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
[TBL] [Abstract][Full Text] [Related]
8. Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug-gene interaction networks analysis.
MotieGhader H; Tabrizi-Nezhadi P; Deldar Abad Paskeh M; Baradaran B; Mokhtarzadeh A; Hashemi M; Lanjanian H; Jazayeri SM; Maleki M; Khodadadi E; Nematzadeh S; Kiani F; Maghsoudloo M; Masoudi-Nejad A
Sci Rep; 2022 Jun; 12(1):9417. PubMed ID: 35676421
[TBL] [Abstract][Full Text] [Related]
9. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
Lago SG; Bahn S
ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
[TBL] [Abstract][Full Text] [Related]
10. Trimming of mammalian transcriptional networks using network component analysis.
Tran LM; Hyduke DR; Liao JC
BMC Bioinformatics; 2010 Oct; 11():511. PubMed ID: 20942926
[TBL] [Abstract][Full Text] [Related]
11. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
Zhang J; Le TD; Liu L; He J; Li J
Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
[TBL] [Abstract][Full Text] [Related]
12. Candidates for drug repurposing to address the cognitive symptoms in schizophrenia.
Koch E; Kauppi K; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110637. PubMed ID: 36099967
[TBL] [Abstract][Full Text] [Related]
13. DiNeR: a Differential graphical model for analysis of co-regulation Network Rewiring.
Zhang J; Liu J; Lee D; Lou S; Chen Z; Gürsoy G; Gerstein M
BMC Bioinformatics; 2020 Jul; 21(1):281. PubMed ID: 32615918
[TBL] [Abstract][Full Text] [Related]
14. Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer's disease.
Gupta C; Xu J; Jin T; Khullar S; Liu X; Alatkar S; Cheng F; Wang D
PLoS Comput Biol; 2022 Jul; 18(7):e1010287. PubMed ID: 35849618
[TBL] [Abstract][Full Text] [Related]
15. Analyzing miRNA co-expression networks to explore TF-miRNA regulation.
Bandyopadhyay S; Bhattacharyya M
BMC Bioinformatics; 2009 May; 10():163. PubMed ID: 19476620
[TBL] [Abstract][Full Text] [Related]
16. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
[TBL] [Abstract][Full Text] [Related]
17. A novel microRNA and transcription factor mediated regulatory network in schizophrenia.
Guo AY; Sun J; Jia P; Zhao Z
BMC Syst Biol; 2010 Feb; 4():10. PubMed ID: 20156358
[TBL] [Abstract][Full Text] [Related]
18. MNBDR: A Module Network Based Method for Drug Repositioning.
Chen HG; Zhou XH
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375395
[TBL] [Abstract][Full Text] [Related]
19. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
[TBL] [Abstract][Full Text] [Related]
20. Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia.
Xu Y; Yue W; Yao Shugart Y; Li S; Cai L; Li Q; Cheng Z; Wang G; Zhou Z; Jin C; Yuan J; Tian L; Wang J; Zhang K; Zhang K; Liu S; Song Y; Zhang F
Schizophr Bull; 2016 Jul; 42(4):1037-45. PubMed ID: 26609121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
